LncRNA-HOXB-AS3 peptide suppressed colon cancer (CRC) growth through blocking hnRNPA1-mediated PKM splices, thereby inhibiting the formation of PKM2 and suppressing the reprogramming of the glucose metabolism (Huang et al., 2017). This evidence concerns the gene PKM and malignant colon neoplasm.